test

Hongbo Bao

@Decheng Capital Llc

Latest period2024 - Q3ReportedManaged Assets$422.193MTotal holdings26
Assets growth rate29.39%Assets growth rate (2-Q avg)-13.42%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Decheng Capital Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 26 positions.

Assets under management

The assets under management (AUM) of Decheng Capital Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 422.193M in assets, with a quarterly growth rate of 29.39% and a 2-quarter average growth rate of -13.42%. The portfolio is managed by Hongbo Bao, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MLTXMoonlake Immunotherapeutics
Recent Activity
1.99%
$8.4M
166,600 shares@ $50.42 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
1.92%
$8.072M
157,958 shares@ $51.11 avg price
LEGNLegend Biotech Corp-adr
Recent Activity
Increased 10.15%
1.26%
$5.29M
108,558 shares@ $48.73 avg price
CYTKCytokinetics Inc
Recent Activity
1.18%
$4.965M
94,043 shares@ $52.8 avg price
AURAAura Biosciences, Inc.
Recent Activity
1.09%
$4.594M
515,555 shares@ $8.91 avg price
WGSGenedx Holdings Corp.
Recent Activity
1.05%
$4.397M
103,604 shares@ $42.44 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 14.38%
1.02%
$4.301M
397,835 shares@ $10.81 avg price
EQEquillium Inc.
Recent Activity
0.88%
$3.7M
4.447M shares@ $0.84 avg price
VERAVera Therapeutics Inc
Recent Activity
0.74%
$3.084M
69,767 shares@ $44.2 avg price
LBPHLongboard Pharmaceuticals In
Recent Activity
New Position
0.45%
$1.878M
56,350 shares@ $33.34 avg price